US Stock MarketDetailed Quotes
NVNOW ENVVENO MED CORP C/WTS 30/05/2023 (TO PUR COM)
- 0.0063
- 0.00000.00%
Close May 30 09:30 ET
0Market Cap0.00P/E (TTM)
0.0000High0.0000Low0Volume0.0000Open0.0063Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)0Shares0.023752wk High0.00P/B0Float Cap0.006052wk Low--Dividend TTM0Shs Float0.5500Historical High--Div YieldTTM0.00%Amplitude0.0060Historical Low--Avg Price1Lot Size
About ENVVENO MED CORP C/WTS 30/05/2023 (TO PUR COM) Company
enVVeno Medical Corp is a medical device company focused on the development of innovative bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. Its lead product, the VenoValve, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).
Company Profile
SymbolNVNOW
Company NameENVVENO MED CORP C/WTS 30/05/2023 (TO PUR COM)
CEOMr. Robert A. Berman
MarketNASDAQ
Employees30
Fiscal Year Ends12-31
Websitehttps://www.envveno.com
Company Executives
- Name
- Position
- Salary
- Robert A. Berman
- Director and Chief Executive Officer
- 466.48K
- Craig Glynn
- Principal Accounting Officer, Chief Financial Officer and Treasurer
- 228.82K
- Dr. Marc H. Glickman, M.D.
- Senior Vice President and Chief Medical Officer
- 404.97K
- Hamed Alavi
- Senior Vice President and Chief Technology Officer
- 728.00K
- Dr. Sanjay Shrivastava
- Independent Director
- 75.00K
- Matthew Jenusaitis
- Independent Director
- 75.00K
- Dr. Francis Duhay
- Independent Director
- 70.00K
- Robert C. Gray
- Independent Director
- 77.50K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data